Incidence of Platelet Dysfunction by Thromboelastography-Platelet Mapping in Children Supported with ECMO: A Pilot Retrospective Study. (scientific article)

Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review

Q30595449

The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates

Q33333372

Inhaled nitric oxide inhibits the release of matrix metalloproteinase-2, but not platelet activation, during extracorporeal membrane oxygenation in adult rabbits

Q33347331

Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO).

Q33582560

The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation

Q33710364

Mechanisms and attenuation of hemostatic activation during extracorporeal circulation

Q34448250

How platelets work: platelet function and dysfunction

Q35647744

Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets

Q35816269

Association of bleeding and thrombosis with outcome in extracorporeal life support.

Q36161716

Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation

Q36494829

Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey

Q36595061

Anticoagulation and coagulation management for ECMO.

Q37600544

Evaluation of Heparin Assay for Coagulation Management in Newborns Undergoing ECMO

Q37810702

Drugs that affect platelet function

Q38056663

Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion

Q38197849

Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation

Q38244377

Whole blood activated clotting time in infants during extracorporeal membrane oxygenation

Q41192876

Prospective observational study of hemostatic alterations during adult extracorporeal membrane oxygenation (ECMO) using point-of-care thromboelastometry and platelet aggregometry

Q41474039

The blind physicians and the elephant on extracorporeal membrane oxygenation

Q44671808

Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques

Q46464536

Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation

Q46721773

Platelet mapping as part of modified thromboelastography (TEG®) in patients undergoing cardiac surgery and cardiopulmonary bypass

Q48145829

Point-of-care coagulation monitoring: applications of the thromboelastography.

Q51511686

Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib

Q53061821

Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules

Q58313835

Effect of extracorporeal membrane oxygenation on platelets in newborns

Q72801120

Effects of milrinone on platelet aggregation in swine with pulmonary hypertension

Q73021971

The effects of nitric oxide on coagulation during simulated extracorporeal membrane oxygenation

Q73477247

Coagulation monitoring during extracorporeal membrane oxygenation: the role of thrombelastography

Q77051181

Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation

Q79610257

Reference values for kaolin-activated thromboelastography in healthy children

Q80100445

A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass

Q80566180

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients

Q84853003

The effect of inhaled nitric oxide therapy on thromboelastogram in newborns with persistent pulmonary hypertension

Q87801293

P921

main subject

extracorporeal membrane oxygenation

Q1385195

P304

page(s)

116

P577

publication date

2015-01-01

P1433

published in

Frontiers in pediatrics

Q27725038

P1476

title

Incidence of Platelet Dysfunction by Thromboelastography-Platelet Mapping in Children Supported with ECMO: A Pilot Retrospective Study

P478

volume

Reverse relations

cites work (P2860)

Q33760799	Anticoagulation Therapy during Extracorporeal Membrane Oxygenator Support in Pediatric Patients
Q90403358	Anticoagulation in Neonatal ECMO: An Enigma Despite a Lot of Effort!
Q97537719	Awake veno-arterial extracorporeal membrane oxygenation in patients with perioperative period acute heart failure in cardiac surgery
Q90092085	Bleeding and Thrombosis With Pediatric Extracorporeal Life Support: A Roadmap for Management, Research, and the Future From the Pediatric Cardiac Intensive Care Society: Part 2
Q42339324	Evidence of altered haemostasis in an ovine model of venovenous extracorporeal membrane oxygenation support
Q92738999	Low flow rate alters haemostatic parameters in an ex-vivo extracorporeal membrane oxygenation circuit
Q58556306	Neonatal ECMO
Q90373833	Platelet Transfusion Practice and Related Outcomes in Pediatric Extracorporeal Membrane Oxygenation
Q61835226	Platelet-mapping assay for monitoring antiplatelet therapy during mechanical circulatory support in children: A retrospective observational study
Q90010631	Prevalence of aspirin resistance by thromboelastography plus platelet mapping in children with CHD: a single-centre experience
Q92542248	TEG Platelet Mapping and Impedance Aggregometry to Predict Platelet Transfusion During Cardiopulmonary Bypass in Pediatric Patients
Q40542538	The delicate balance between pro-(risk of thrombosis) and anti-(risk of bleeding) coagulation during extracorporeal membrane oxygenation
Q57164721	Use of Thromboelastography to Predict Thrombotic Complications in Pediatric and Neonatal Extracorporeal Membranous Oxygenation